Endonovo Therapeutics (ENDV) Receivables - Other (2023)
Endonovo Therapeutics has reported Receivables - Other over the past 2 years, most recently at $5215.0 for Q3 2023.
- Quarterly results put Receivables - Other at $5215.0 for Q3 2023, changed N/A from a year ago — trailing twelve months through Sep 2023 was $5215.0 (changed N/A YoY), and the annual figure for FY2010 was $9336.0, changed.
- Receivables - Other for Q3 2023 was $5215.0 at Endonovo Therapeutics, up from $250.0 in the prior quarter.
- Over the last five years, Receivables - Other for ENDV hit a ceiling of $5215.0 in Q3 2023 and a floor of $250.0 in Q1 2023.